; DiObex, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

DiObex, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

VIEWS: 2 PAGES: 16

DiObex, Inc. (DiObex) is a biotechnology company, based in the US. The company develops novel products for the treatment of metabolic disorders. The metabolic disorders include type-one and type-two diabetes, dyslipidemia, obesity, and diabetic nephropathy. DiObex products include DIO-901, a very low dose glucagon product that is developed for the reduction of nocturnal hypoglycemia in patients with type-one diabetes. The company’s product DIO-902 is a cortisol synthesis inhibitor that is developed as a therapy for glucose and cholesterol control in patients with type-two diabetes. The company also provides development of therapeutics to treat metabolic diseases. DiObex is headquartered in San Francisco, California, the US.

More Info
  • pg 1
									           DiObex, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
       Reference Code: GDPH189192D                                                                                                             Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      DiObex, Inc. (DiObex) is a biotechnology company, based in the US. The company
                                                                                                              DiObex, Inc., Pharmaceuticals & Healthcare, Key
      develops novel products for the treatment of metabolic disorders. The metabolic
                                                                                                              Facts
      disorders include type-one and type-two diabetes, dyslipidemia, obesity, and
      diabetic nephropathy. DiObex products include DIO-901, a very low dose glucagon                          Web Address                           www.diobex.com
      product that is developed for the reduction of nocturnal hypoglycemia in patients
                                                                                                               Revenue (US$ million)                                NA
      with type-one diabetes. The company’s product DIO-902 is a cortisol synthesis
      inhibitor that is developed as a therapy for glucose and cholesterol control in                          Number of Employees                                  NA
      patients with type-two diabetes. The company also provides development of                                GlobalData
      therapeutics to treat metabolic diseases.

      Financial Deals Landscape
        DiObex, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007                   DiObex, Inc., Pharmaceuticals & Healthcare, Deals By Year,
        to YTD 2013                                                                       2007 to YTD 2013


                                                                                                                           2
                                                                                                          2




                                                                                           No. of Deals
                                                                                                                 1
                                                                                                          1


                                                                                                                                  0        0         0    0          0
                                                                                                          0
                                                                                                               2007       2008   2009     2010   2011    2012       YTD
                                                                                                                                                                    2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


                                                                                          DiObex, Inc., Pharmaceuticals & Healthcare, Deals By
                                                                                          Therapy Area, 2007 to YTD 2013


                                                                                                                      3
                                                                                                          3
                                                                                           No. of Deals




                                                                                                          2
                                                                                                                                      1
                                                                                                          1
                                                                                                                                                 0              0
                                                                                                          0
                                                                                                                 Metabolic Cardiova            Central   Gastroint
                                                                                                                 Disorder   scular             Nervous    estinal
                                                                                                                    s                          System



                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
                                                                                          from 2006 onwards, GlobalData




DiObex, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances                                                                                Reference Code: GDPH189192D
Profile
Source : www.globalcompanyintelligence.com                                                                                                                                  Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       DiObex, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 .............................................................................. 4
       DiObex, Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 .............................................................................. 5
       DiObex, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ................................................................ 6
       DiObex, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ........................................................................... 7
       DiObex, Inc., Pharmaceuticals & Healthcare, Deal Details ................................................................................................................ 8
          Venture Financing........................................................................................................................................................................... 8
             DiObex Raises $17 Million In Series C Financing ....................................................................................................................... 8
             DiObex Secures $24 Million In Series B Financing ................................................................................................................... 10
          Licensing Agreements .................................................................................................................................................................. 12
             DiObex Enters Into Licensing Agreement With Camurus .......................................................................................................... 12
       DiObex, Inc. - Key Competitors ........................................................................................................................................................ 14
       Locations And Subsidiaries .............................................................................................................................................................. 15
          Head Office ................................................................................................................................................................................... 15
       Appendix .......................................................................................................................................................................................... 16
          Methodology ................................................................................................................................................................................. 16
          About GlobalData ......................................................................................................................................................................... 16
          Contact Us .................................................................................................................................................................................... 16
          Disclaimer ..................................................................................................................................................................................... 16




DiObex, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances                                                                                                Reference Code: GDPH189192D
Profile
Source : www.globalcompanyintelligence.com           
								
To top